Solving Kids’ Cancer’s approach is to understand the research landscape, strengthen the science, cure, and care for the child. The GD2 T Cell Therapy trial at Texas Children’s Hospital is helping children with neuroblastoma like Kyra Kardong – listen to her story.
The Solving Kids Cancer 6th Annual Spring Celebration was held June 8 at 583 Park Avenue, raising $650,000 for childhood cancer research. This year’s Spring Celebration honored Roger Jeffs, PhD, president and Co-CEO of United Therapeutics, and Yoganathan Ratheesan, Founder and Chairman of Lebara Group.
Anonymous Donor agreed to donate $1 for every share up to $10,000 for Childhood Cancer Awareness Month
September is National Childhood Cancer Awareness Month, and the concept is simple: to join Solving Kids’ Cancer in honoring those children who are undergoing treatment, celebrating those who have won the battle, and remembering those who we have lost by sharing social media posts with the hashtag #CCAM throughout the month. The anonymous donor has agreed to donate $1 for every share up to $10,000.
Recently, the potential of oncolytic viruses to treat deadly cancers was featured in a segment of 60 Minutes, which highlighted the work of Matthias Gromeier, MD, at Duke University. Solving Kids’ Cancer has been in discussion with Dr. Gromeier since 2012 to find a way to best bring this novel treatment option to children with deadly brain tumors.
Immunotherapy is changing the paradigm for children with cancer. Solving Kids’ Cancer has teamed up with the same researchers who helped save Emily Whitehead’s life to bring a new treatment option for children with neuroblastoma. Meet one family that was on a Solving Kids’ Cancer clinical trial at the Children’s Hospital of Philadelphia
Childhood cancer fighters and survivors ages 3-13 walked the runway in Bloomingdale’s on 59th Street. With the help of everyone involved the event was a complete success and the children in their hand-picked outfits truly earned the title “Runway Heroes”. Watch the 2014 fashion show here!
Jordyn being diagnosed at 6 months old with neuroblastoma was a devastating shock for her mother, Jodie. After 6 ineffective rounds of chemotherapy, radiation, and surgery Jodie was left without any options, which in turn lead her to an experimental clinical trial sponsored by Solving Kids’ Cancer. This is the story of their journey to save Jordyn.
Al Jazeera America covered the story of Solving Kids’ Cancer’s co-founders, Scott Kennedy & John London, and why they created the organization. Listen in on their stories and the inspiration behind the making of Solving Kids’ Cancer.
Solving Kids’ Cancer’s co-founder, John London, share the story of how he stumbled upon Nifurtimox as a treatment option for neuroblastoma and brought it to a Phase 1 clinical trial. Listen in as we interview Dr. Giselle Sholler as she speaks on her clinical trial that was one of the first trials SKC funded.